Ethics and commercial insurance  by Jones, James W et al.
SURGICAL ETHICS CHALLENGES
James W. Jones, MD, PhD, MHA, Surgical Ethics Challenges Section Editor
Ethics and commercial insurance
James W. Jones, MD, PhD, MHA,a Laurence B. McCullough, PhD,a and Bruce W. Richman, MA,bHouston, Tex, and Columbia, MoYou have just seen a 59-year-old diabetic woman
with a several year history of debilitating claudication
that has recently progressed to rest pain. She has just
changed employers, and her new health insurance plan
specifically excludes pre-existing conditions. She ex-
plains that she did not specify her peripheral vascular
disease symptoms on her enrollment form because she
considered them muscle spasms. To obtain treatment
approval from the insurer, your billing clerk needs to
know whether or not the condition pre-existed. Your
response?
A. Get the approval by whatever means necessary. It is
ethical to skirt insurer’s restrictions to help your pa-
tient.
B. Call the insurer and formally appeal on the patient’s
behalf.
C. Tell the patient to call an attorney.
D. Petition your congressional representatives to enact laws
prohibiting pre-existing condition clauses in private
plans.
E. Tell your patient to quit her job and apply for Medicaid.
Many complex ethical and economic problems are di-
rectly entangled with management of commercial health
insurance.1 Our culture is ambivalent about whether health
care is a right or a privilege, with opinions varying on the
basis of the population segments in question and the pro-
viding institution. The custom of employer-supported
commercial health insurance began in the United States
during the Great Depression, when hospitals were unable
to collect reimbursements and a few large organizations
wanted their employees to return quickly to health and to
work.2 Employer-provided health insurance expanded dur-
ing World War II, when the imposition of wage and price
controls on a wartime economy resulted in non-wage ben-
efits becoming an important management tool in the re-
cruitment and retention of scarce, skilled labor. After the
war, with strong unions and a strong American economy,
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insurance became even more common methods for recruit-
ing and retaining valued employees and improving their
productivity. The private health insurance that is now a
feature of most full-time permanent jobs in the United
States reached that status through a series of self-interested
business decisions and historical accidents rather than as a
result of deliberate public policy decisions to create a right
to health care.3 Although the expansion of government-
subsidized Medicare and Medicaid programs strains the
boundaries of the question, commercial health insurance
has never become an individual right in American law.
Third-party support for health care has nevertheless
been not only widespread, but also ever-widening in Amer-
ica for nearly three quarters of a century, about a third of
our national history. It has affected nearly every living
person in the country in one way or another, and what
began as an innovation and grew to be a custom has by now
come to be considered normative, and assumed to be an
entitlement of every worker. From this perspective, the
failure of this patient’s new employer to provide coverage
for the management of her claudication seems pitiless and
morally reprehensible—self-serving capitalism in one of its
worst aspects. Seen this way, option A would be the clearly
justified response to this patient’s plight.
Although implementing this option might make a sur-
geon feel like a crusader for social justice, doing so and
feeling so would involve serious ethical errors. Surgeons
surely have fiduciary relationships with their patients. Sur-
geons are to be competent in their fund of knowledge and
clinical skills and use them to the primary benefit of their
patients.4 Fiduciary responsibility for patients, however,
does not create a moral authority to consume resources that
neither the surgeon nor the patient own, and which in this
case belong to the insurance company contracted by the
patient’s employer.5 From her response, one can assume
that this patient’s employer and the insurer, as part of her
employment, explained the nature and limits of the health
benefits package. The exclusion of pre-existing conditions
on a new hire is not uncommon and is permitted by law. In
a society that is committed to the rule of law, the law
commands our moral respect and compliance.
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falsify insurance claims to cover the expense of their pa-
tients’ therapy for peripheral vascular disease to be paid.6
However nobly considered, this behavior qualifies as nei-
ther political activism, civil disobedience, nor proper benef-
icence. It is merely criminal deception and, at worst, has as
its intent a guarantee that someone will pay the physician. If
we think that a law is ethically unjustified we may work to
change it through the political or judicial process. A judicial
challenge would involve open disobedience to the law with
the intention of provoking criminal or civil litigation, and a
willingness to accept attendant consequences, not falsifica-
tion of records. Option A is therefore ruled out altogether.
Option D surely fulfills one’s obligation as a citizen of
conscience, and would therefore be a good thing to do in
this case, but it does nothing to address the immediate
problem.
If it is true that this patient reported her muscle spasms
without knowing the cause of them, she still has a pre-
existing condition. Reliable clinical judgment cannot place
her claudication in any other category, given that it is a
chronic condition with chronic symptoms. As a matter of
professional integrity, which requires the surgeon to prac-
tice to standards of intellectual and moral excellence, the
surgeon must be honest both with the patient and with her
insurer. The surgeon in this case should respond to the
billing clerk’s query with a clear statement that the patient
has a pre-existing condition. The surgeon should then
explain to the patient that this is what has been done.
The surgeon should also explain, however, that this is
not the end of the matter. Fiduciary responsibility clearly
directs the surgeon in this case to offer and implement
clinical management appropriate to the patient’s diagnosis.
Fiduciary responsibility includes an obligation to undertake
reasonable advocacy on behalf of the patient, especially for
payment for the management of a painful and increasingly
debilitating condition.5,7 Option B emerges on this ac-
count as the most ethically appropriate next step, after
honest reporting through the billing clerk. This option of
refraining from deception and fulfilling patient fiduciary
obligations through an appeal process is the recommended
policy of the American Medical Association’s Council on
Ethical and Judicial Affairs.8 Options C and E are not
acceptable because they assume that the surgeon has nofiduciary responsibility of reasonable advocacy for this pa-
tient; they also amount to a kind of moral abandonment
that itself would be insupportable.
Although the short-term results of deceiving insurance
payers has benefits for both patients and surgeons, Sade9
notes several undesirable long-term effects: (1) the fraud
may be detected, with legal or social consequences; (2) the
physician’s own integrity is compromised and virtue is
eroded; (3) the physician-patient relationship is compro-
mised (“If this physician lies to them, will he lie to me?”);
(4) a potential for future diagnostic confusion is created;
and (5) systemic problems with health care remain unad-
dressed and unresolved.
Delivery of medical care requires knowledge and re-
sources. As long as physicians decline to acknowledge their
partnership and mutual responsibilities with third-party
payers, some obligations will go unmet. Physicians are the
initiators and principals in our health care system, but the
other participants, including commercial third-party insur-
ers, are essential as well. Provision of medical care could not
proceed without the cooperation and mutual integrity of
each these major participants.
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